ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Total liabilities

annual total liabilities:

$454.96M+$137.76M(+43.43%)
December 31, 2024

Summary

  • As of today (August 30, 2025), ACAD annual total liabilities is $454.96 million, with the most recent change of +$137.76 million (+43.43%) on December 31, 2024.
  • During the last 3 years, ACAD annual total liabilities has risen by +$295.74 million (+185.73%).
  • ACAD annual total liabilities is now at all-time high.

Performance

ACAD Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

quarterly total liabilities:

$403.17M+$36.05M(+9.82%)
June 30, 2025

Summary

  • As of today (August 30, 2025), ACAD quarterly total liabilities is $403.17 million, with the most recent change of +$36.05 million (+9.82%) on June 30, 2025.
  • Over the past year, ACAD quarterly total liabilities has increased by +$5.77 million (+1.45%).
  • ACAD quarterly total liabilities is now -11.38% below its all-time high of $454.96 million, reached on December 31, 2024.

Performance

ACAD quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

ACAD Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+43.4%+1.4%
3 y3 years+185.7%+126.6%
5 y5 years+441.3%+317.2%

ACAD Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+185.7%-11.4%+128.0%
5 y5-yearat high+441.3%-11.4%+317.2%
alltimeall timeat high>+9999.0%-11.4%+6979.4%

ACAD Total liabilities History

DateAnnualQuarterly
Jun 2025
-
$403.17M(+9.8%)
Mar 2025
-
$367.13M(-19.3%)
Dec 2024
$454.96M(+43.4%)
$454.96M(+13.8%)
Sep 2024
-
$399.69M(+0.6%)
Jun 2024
-
$397.40M(+1.6%)
Mar 2024
-
$391.06M(+23.3%)
Dec 2023
$317.20M(+69.3%)
$317.20M(+17.3%)
Sep 2023
-
$270.37M(+9.5%)
Jun 2023
-
$246.98M(-12.1%)
Mar 2023
-
$281.05M(+50.0%)
Dec 2022
$187.40M(+17.7%)
$187.40M(+6.0%)
Sep 2022
-
$176.81M(-0.6%)
Jun 2022
-
$177.92M(-0.9%)
Mar 2022
-
$179.45M(+12.7%)
Dec 2021
$159.23M(+2.3%)
$159.23M(+5.6%)
Sep 2021
-
$150.72M(-5.6%)
Jun 2021
-
$159.59M(-8.1%)
Mar 2021
-
$173.57M(+11.5%)
Dec 2020
$155.61M(+85.1%)
$155.61M(+10.5%)
Sep 2020
-
$140.80M(+45.7%)
Jun 2020
-
$96.64M(-11.4%)
Mar 2020
-
$109.07M(+29.8%)
Dec 2019
$84.05M(+37.5%)
$84.05M(+10.2%)
Sep 2019
-
$76.30M(+6.0%)
Jun 2019
-
$71.97M(-13.0%)
Mar 2019
-
$82.75M(+35.4%)
Dec 2018
$61.12M(+24.2%)
$61.12M(+42.1%)
Sep 2018
-
$43.02M(-14.4%)
Jun 2018
-
$50.24M(+7.2%)
Mar 2018
-
$46.87M(-4.8%)
Dec 2017
$49.22M(+15.2%)
$49.22M(+35.3%)
Sep 2017
-
$36.39M(-11.6%)
Jun 2017
-
$41.17M(-9.5%)
Mar 2017
-
$45.49M(+6.4%)
Dec 2016
$42.74M(+93.1%)
$42.74M(+8.7%)
Sep 2016
-
$39.33M(+34.6%)
Jun 2016
-
$29.22M(+36.9%)
Mar 2016
-
$21.34M(-3.6%)
Dec 2015
$22.13M(+38.6%)
$22.13M(+23.1%)
Sep 2015
-
$17.97M(-8.8%)
Jun 2015
-
$19.72M(+16.9%)
Mar 2015
-
$16.87M(+5.6%)
Dec 2014
$15.97M
$15.97M(+41.6%)
Sep 2014
-
$11.27M(+20.5%)
Jun 2014
-
$9.36M(+16.3%)
DateAnnualQuarterly
Mar 2014
-
$8.05M(+15.2%)
Dec 2013
$6.99M(+17.5%)
$6.99M(-11.2%)
Sep 2013
-
$7.87M(+1.2%)
Jun 2013
-
$7.78M(+36.5%)
Mar 2013
-
$5.70M(-4.3%)
Dec 2012
$5.95M(-32.0%)
$5.95M(-2.3%)
Sep 2012
-
$6.09M(-33.6%)
Jun 2012
-
$9.17M(+2.6%)
Mar 2012
-
$8.93M(+2.1%)
Dec 2011
$8.75M(+0.5%)
$8.75M(-1.4%)
Sep 2011
-
$8.88M(+4.6%)
Jun 2011
-
$8.49M(-3.3%)
Mar 2011
-
$8.78M(+0.8%)
Dec 2010
$8.71M(-76.8%)
$8.71M(-75.8%)
Sep 2010
-
$35.92M(-0.2%)
Jun 2010
-
$36.01M(-0.5%)
Mar 2010
-
$36.17M(-3.7%)
Dec 2009
$37.57M(+221.5%)
$37.57M(-4.9%)
Sep 2009
-
$39.51M(-9.5%)
Jun 2009
-
$43.65M(+264.2%)
Mar 2009
-
$11.98M(+2.6%)
Dec 2008
$11.69M(-43.4%)
$11.69M(-2.3%)
Sep 2008
-
$11.96M(-19.6%)
Jun 2008
-
$14.88M(+1.5%)
Mar 2008
-
$14.66M(-29.0%)
Dec 2007
$20.65M(-7.8%)
$20.65M(+10.9%)
Sep 2007
-
$18.61M(+16.7%)
Jun 2007
-
$15.95M(-15.8%)
Mar 2007
-
$18.95M(-15.3%)
Dec 2006
$22.39M(-3.2%)
$22.39M(-0.6%)
Sep 2006
-
$22.51M(-16.7%)
Jun 2006
-
$27.02M(+14.2%)
Mar 2006
-
$23.66M(+2.3%)
Dec 2005
$23.13M(+138.9%)
$23.13M(+9.8%)
Sep 2005
-
$21.07M(+68.8%)
Jun 2005
-
$12.48M(-7.9%)
Mar 2005
-
$13.55M(+40.0%)
Dec 2004
$9.68M(+6.4%)
$9.68M(-6.8%)
Sep 2004
-
$10.39M(-1.2%)
Jun 2004
-
$10.51M(-7.1%)
Mar 2004
-
$11.32M(-86.6%)
Dec 2003
$9.10M(-5.3%)
$84.36M
Dec 2002
$9.61M(+134.6%)
-
Dec 2001
$4.10M(-92.8%)
-
Dec 2000
$56.62M
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual total liabilities?
  • What is the all time high annual total liabilities for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual total liabilities year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly total liabilities?
  • What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly total liabilities year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual total liabilities?

The current annual total liabilities of ACAD is $454.96M

What is the all time high annual total liabilities for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual total liabilities is $454.96M

What is ACADIA Pharmaceuticals Inc. annual total liabilities year-on-year change?

Over the past year, ACAD annual total liabilities has changed by +$137.76M (+43.43%)

What is ACADIA Pharmaceuticals Inc. quarterly total liabilities?

The current quarterly total liabilities of ACAD is $403.17M

What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly total liabilities is $454.96M

What is ACADIA Pharmaceuticals Inc. quarterly total liabilities year-on-year change?

Over the past year, ACAD quarterly total liabilities has changed by +$5.77M (+1.45%)
On this page